Comparative ICSI Outcomes in Idiopathic Male Factor and Unexplained Infertility: A Retrospective Cohort Study
DOI:
https://doi.org/10.38029/babcockuniv.med.j..v9i2.1409Keywords:
ICSI, Pregnancy rate, Idiopathic infertility, Unexplained sub-fertility, Male sub-fertilityAbstract
Objective: To compare ICSI outcomes in couples with idiopathic male factor sub-fertility versus unexplained sub-fertility.
Methods: This retrospective cohort study was conducted at Al-Kafeel IVF Centre, Karbala, Iraq, and included 98 couples who underwent ICSI between February 2023 and January 2024. Of these, 62 had idiopathic male factor sub-fertility and 36 had unexplained sub-fertility. All underwent conventional ICSI. Outcomes assessed were fertilisation rate, cleavage rate, total embryos, good-quality embryos, and biochemical pregnancy confirmed by positive β-hCG.
Results: Fertilisation rates were 73.2% ± 25.6 (idiopathic) vs 79.5% ± 22.9 (unexplained), p = 0.39; cleavage rates 95.2% ± 18.1 vs 97.8% ± 5.0, p = 0.56. Total embryos (mean ± SD) were lower in the idiopathic group (3.9 ± 2.6) than in the unexplained group (7.2 ± 4.7), p = 0.003; good-quality embryos 3.5 ± 2.4 vs 6.6 ± 4.1, p = 0.002. Biochemical pregnancy occurred in 32/62 (51.6%) idiopathic versus 14/36 (38.9%) unexplained. Unadjusted odds ratio for pregnancy (idiopathic vs unexplained) = 1.68 (95% CI 0.73–3.86), Fisher’s exact p = 0.29. After adjustment for maternal age, BMI, total oocytes and number of embryos transferred (multivariable logistic regression), the group effect was [report aOR here once analysis is run].
Conclusions: Idiopathic male factor sub-fertility is associated with lower embryo yield and fewer good-quality embryos after ICSI, but biochemical pregnancy rates did not differ significantly. Future studies should adjust for embryo transfer policy and include live birth outcomes.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Hussein SS, Al-Dulaimi AIR, Hassan MF

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
